Hapila's counter-current crystallisation process provides a cost effective procedure for purification of active pharmaceutical ingredients, completed by experience in synthesis and particle design.

Press releases

23. September 2008

High-Tech Gründerfonds invests in Thuringian Technology Venture „HAPILA GmbH“

Start-up from Gera offers high-efficiency processes for purification of Active Pharmaceutical Ingredients The shareholders and staff of HAPILA GmbH, a provider of sophisticated pharmaceutical and chemical development services located in Gera, are delighted to announce that the High-Tech Gründerfonds has invested in their company. “With this engagement by the HTGF, the ideal foundations have been laid to commercialize our high-tech crystallization technology” - said CEO, Dr. Uwe Müller. T

Info & Contact

Dr. Uwe Müller


Otto Schott Straße 9
7552 Gera

In portfolio

28. Aug 2008